Daily Bulletin

Men's Weekly

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Nutifood Partners With GippsNature for First Product Launch, Eyeing Global Growth

The Victorian Government delegation joined discussions during the visit The first GippsNature product signals a new chapter in Vietnam - Australia dairy ties. A New Cross-Border Dairy Initiative ...

Daily Bulletin - avatar Daily Bulletin

5 Tips for Maintaining Outdoor Furniture in Rentals

Think outdoor furniture is low-maintenance? Tell that to the sun, the rain, and the occasional possum that decides to test it out. If you’re managing a property, that outdoor setup isn’t just for sho...

Daily Bulletin - avatar Daily Bulletin

Finding the Best Removalists in Geelong, Victoria: What You Need to Know

Moving to a new home or office can be both exciting and stressful. The process involves a lot of planning, coordination, and effort to ensure that everything runs smoothly. One of the most important d...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business